The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance

Safety of Active Immunotherapy in Subjects With Ovarian Cancer

NCT01456065 ·Status: UNKNOWN ·Phase: PHASE1

Ovarian Tumor Biopsies to Study Response to Treatments

NCT02952521 ·Status: COMPLETED

Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

NCT01000259 ·Status: RECRUITING

Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary

NCT00626873 ·Status: COMPLETED ·Phase: PHASE1

Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO

NCT06917469 ·Status: COMPLETED

Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve

NCT00712452 ·Status: TERMINATED ·Phase: NA

Comparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage Ovarian Cancer

NCT03448354 ·Status: UNKNOWN ·Phase: NA

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

NCT00501644 ·Status: COMPLETED ·Phase: PHASE2

Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment

NCT04435964 ·Status: COMPLETED

Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels

NCT00083928 ·Status: COMPLETED ·Phase: PHASE2

Phase III Trial of Stage I Ovarian Cancer After Surgery

NCT04063527 ·Status: RECRUITING ·Phase: PHASE3

Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer

NCT01606358 ·Status: WITHDRAWN

Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer

NCT01680575 ·Status: UNKNOWN

Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer

NCT02711865 ·Status: UNKNOWN

Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

NCT00045461 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study

NCT06085456 ·Status: RECRUITING

Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer

NCT00189579 ·Status: TERMINATED ·Phase: PHASE2

Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer

NCT03249142 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03188432 ·Status: COMPLETED ·Phase: PHASE2

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

NCT00660101 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Tumor Microenvironment in Ovarian Cancer

NCT06272240 ·Status: RECRUITING

Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer

NCT02480374 ·Status: COMPLETED ·Phase: PHASE1

Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants

NCT00628654 ·Status: COMPLETED

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

NCT05316129 ·Status: RECRUITING ·Phase: PHASE1

Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer

NCT04072263 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2